Harrow HROW is set to give its latest quarterly earnings report on Thursday, 2025-05-08. Here's what investors need to know before the announcement. Analysts estimate that Harrow will report an ...

Harrow's relaunch of Triesence, a preservative-free corticosteroid, addresses a critical unmet need in ophthalmology, offering safer and more effective treatment options for eye care professionals ...

Wasatch Micro Cap Value Strategy featured stocks like Harrow, Inc. (NASDAQ:HROW) in the fourth quarter 2023 investor letter. Headquartered in Nashville, Tennessee, Harrow, Inc. (NASDAQ:HROW ...

Harrow reported a $20 million loss for the first half of 2024, doubling from the previous year. Increased competition from generics and new drugs will squash margins. Harrow's recent strategy ...

Harrow (NASDAQ:HROW) is set to give its latest quarterly earnings report on Thursday, 2025-05-08. Here's what investors need to know before the announcement. Analysts estimate that Harrow will ...